ArticleCancers2023

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker.

Xinna Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.